I feel it's worth pointing out that with Dr. Lalezari's experience and contacts in San Francisco, specifically in the LBGTQ community, through his past HIV work and his clinic, I imagine he'll be able to recruit patients for the hyper-inflammation trial rather quickly. Certainly much faster than we would with a different CEO.

Would still like to know what Dr J's planned timeline is.